Magnetic and/or Radiopaque Functionalization of Self-Unfolding Foils for Improved Applicability within Oral Drug Delivery
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Various types of microfabricated devices have been proposed for overcoming the gastrointestinal (GI) challenges associated with oral administration of pharmaceutical compounds. However, unidirectional drug release in very close forced proximity to the intestinal wall still appears to be an unresolved issue for many of these microdevices, which typically show low drug absorption and thereby low bioavailabilities. This work explores how recently developed and promising self-unfolding foils (SUFs) can be magnetically and/or radiopaquely (M/R-) functionalized, by the addition of BaSO 4 or Fe 3 O 4 nanoparticles, for improving their applicability within oral drug delivery. Through surface characterization, mechanical testing, and X-ray imaging, the (M/R-)SUFs are generally inspected and their overall properties compared. Furthermore, R-SUFs are being used in an in vivo rat X-ray imaging study, whereas in situ rat testing of MR-SUFs are attempted together with an investigation of their general magnetic properties. Unfolding of the R-SUF, and its very close forced proximity to the small intestine, is very easily observed 2 h post-administration by applying both computed tomography scanning and planar X-ray imaging. In addition, MR-SUFs show a great magnetic response in water, which suggests the possibility for controlled motion and retention in the GI tract. However, the magnetic response does not seem strong enough for in situ rat testing, but most likely a strong magnetization of the MR-SUFs using for example an impulse magnetizer can be made for increasing the magnetic response. All of the results presented herein are highly relevant and applicable for future usage of (M/R-)SUFs, as well as similar devices, in pre-clinical studies and potential clinical trials.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Characterization and Applications of Magnetic Nanoparticles · Nanoparticle-Based Drug Delivery · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The Danish National Research Foundation and Villum Foundation’s Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics (IDUN), Department of Health Technology, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
Funding
European Research Council · Danmarks Grundforskningsfond · Villum Fonden
References (46)
Show source-provided references
1. 10.3389/fphar.2021.61841110.3389/fphar.2021.618411 ↗
2. 10.1016/S1056-8719(00)00113-110.1016/S1056-8719(00)00113-1 ↗
3. Pharmaprojects · 2022
4. Pharmaprojects · 2021
5. Hetal T. · Int. J Pharm Sci Rev Res · 2010 · 4 · 203
6. 10.1517/17425247.2.1.2910.1517/17425247.2.1.29 ↗
7. 10.1080/17425247.2020.178958710.1080/17425247.2020.1789587 ↗
8. 10.1039/C8LC00408K10.1039/C8LC00408K ↗
9. 10.1016/j.jjcc.2017.03.00510.1016/j.jjcc.2017.03.005 ↗
10. 10.1016/j.coph.2017.08.00510.1016/j.coph.2017.08.005 ↗
11. 10.1080/1061186X.2017.130066410.1080/1061186X.2017.1300664 ↗
12. 10.1002/jps.2418210.1002/jps.24182 ↗
13. 10.1038/s41591-019-0606-010.1038/s41591-019-0606-0 ↗
14. 10.1021/acsnano.6b0080910.1021/acsnano.6b00809 ↗
15. 10.1126/sciadv.abb413310.1126/sciadv.abb4133 ↗
16. 10.1016/j.ejpb.2019.08.01110.1016/j.ejpb.2019.08.011 ↗
17. 10.1016/j.jconrel.2020.10.02410.1016/j.jconrel.2020.10.024 ↗
18. 10.1016/j.ijpharm.2011.07.03110.1016/j.ijpharm.2011.07.031 ↗
19. 10.1007/s11095-019-2608-510.1007/s11095-019-2608-5 ↗
20. 10.1002/ccd.125010.1002/ccd.1250 ↗
21. 10.3390/pharmaceutics1201008110.3390/pharmaceutics12010081 ↗
22. 10.1016/j.ijpharm.2010.01.00110.1016/j.ijpharm.2010.01.001 ↗
23. 10.1021/acsbiomaterials.1c0022510.1021/acsbiomaterials.1c00225 ↗
24. 10.1016/j.addr.2021.05.02410.1016/j.addr.2021.05.024 ↗
25. 10.4155/tde.11.13710.4155/tde.11.137 ↗
26. 10.1002/adma.20210493210.1002/adma.202104932 ↗
27. 10.1039/D1NJ00419K10.1039/D1NJ00419K ↗
28. 10.3390/polym906019110.3390/polym9060191 ↗
29. 10.1134/S102995992203007910.1134/S1029959922030079 ↗
30. 10.1039/D0TC00373E10.1039/D0TC00373E ↗
31. 10.1016/j.ejpb.2021.07.00710.1016/j.ejpb.2021.07.007 ↗
32. 10.1002/adhm.20220189710.1002/adhm.202201897 ↗
33. 10.1364/JOSAA.1.00061210.1364/JOSAA.1.000612 ↗
34. 10.3390/pharmaceutics1411253610.3390/pharmaceutics14112536 ↗
35. 10.1007/s42791-019-00021-410.1007/s42791-019-00021-4 ↗
36. 10.1039/C4TA05810K10.1039/C4TA05810K ↗
37. 10.1088/0960-1317/24/3/03501710.1088/0960-1317/24/3/035017 ↗
38. 10.1016/0370-1573(81)90014-410.1016/0370-1573(81)90014-4 ↗
39. 10.1208/pt05022910.1208/pt050229 ↗
40. 10.1016/j.jmmm.2009.07.03010.1016/j.jmmm.2009.07.030 ↗
41. 10.1002/adfm.20201091810.1002/adfm.202010918 ↗
42. 10.3390/app11231130110.3390/app112311301 ↗
43. 10.1039/C7RA07944C10.1039/C7RA07944C ↗
44. 10.1002/1522-2586(200007)12:1<2::AID-JMRI2>3.0.CO;2-V10.1002/1522-2586(200007)12:1<2::AID-JMRI2>3.0.CO;2-V ↗
45. 10.1016/j.pbiomolbio.2004.08.00910.1016/j.pbiomolbio.2004.08.009 ↗
46. 10.1016/j.pbiomolbio.2004.08.00710.1016/j.pbiomolbio.2004.08.007 ↗